Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 36, 2023 - Issue 4
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Original Research: Cardiology

Outcomes of surgical Impella placement in acute cardiogenic shock

Timothy J. GeorgeDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, TexasCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0953-0895
, MDORCID Icon,
Jenelle SheasbyDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, Texas
, MSN,
J. Michael DiMaioDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, Texas
, MD,
Nitin KabraDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, Texas
, MD,
David A. RawitscherDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, Texas
, MD &
Aasim AfzalDepartment of Advanced Heart Failure and Mechanical Circulatory Support, Baylor Scott & White The Heart Hospital – Plano, Plano, Texas
, MD
Pages 415-421 | Received 11 Jan 2023, Accepted 13 Apr 2023, Published online: 08 May 2023

  • Chung JS, Emerson D, Ramzy D, et al. A new paradigm in mechanical circulatory support: 100-patient experience. Ann Thorac Surg. 2020;109(5):1370–1377. doi:10.1016/j.athoracsur.2019.08.041.
  • Stretch R, Sauer CM, Yuh DD, et al. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64(14):1407–1415. doi:10.1016/j.jacc.2014.07.958.
  • Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975–2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population based perspective. Circulation. 2009;119(9):1211–1219. doi:10.1161/CIRCULATIONAHA.108.814947.
  • Van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–e268. doi:10.1161/CIR.0000000000000525.
  • Jeger RV, Radovanovic D, Hunziker PR, et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149(9):618–626. doi:10.7326/0003-4819-149-9-200811040-00005.
  • Shah RU, de Lemos JA, Wang TY, et al. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67(7):739–747. doi:10.1016/j.jacc.2015.11.048.
  • Samuels LE, Kaufman MS, Thomas MP, et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14(4):288–293. doi:10.1111/j.1540-8191.1999.tb00996.x.
  • Valente S, Lazzeri C, Vecchio S, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114(2):176–182. doi:10.1016/j.ijcard.2006.01.024.
  • Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010;38(1):152–160. doi:10.1097/CCM.0b013e3181b78671.
  • Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296. doi:10.1056/NEJMoa1208410.
  • Ramzy D, Soltesz E, Anderson M. New surgical circulatory support system outcomes. Asaio J. 2020;66(7):746–752. doi:10.1097/MAT.0000000000001194.
  • Ramzy D, Anderson M, Batsides G, et al. Early outcomes of the first 200 US patients treated with Impella 5.5: a novel temporary left ventricular assist device. Innovations (Phila). 2021;16(4):365–372. doi:10.1177/15569845211013329.
  • Nersesian G, Tschope C, Spillman F, et al. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device. Interact Cardiovasc Thorac Surg. 2020;31(4):475–482. doi:10.1093/icvts/ivaa150.
  • Pahuja M, Hernandez-Montfort J, Whitehead EH, Kawabori M, Kapur NK. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy. Expert Rev Med Devices. 2022;19(1):1–10. doi:10.1080/17434440.2022.2015323.
  • Basir MB, Schreiber TL, Grines CL, et al. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol. 2017;119(6):845–851. doi:10.1016/j.amjcard.2016.11.037.
  • Zubarevich A, Rad AA, Szczechowicz M, et al. Early experience with the Impella pump: single center registry. Artif Organs. 2022;0:1–6.
  • Sugimura Y, Katahira S, Immohr MB, et al. Initial experience covering 50 consecutive cases of large Impella implantation at a single heart centre. ESC Heart Fail. 2021;8(6):5168–5177. doi:10.1002/ehf2.13594.
  • Bashline MJ, Rhinehart Z, Kola O, et al. Impella 5.0 is associated with a reduction in vasoactive support and improves hemodynamics in cardiogenic shock: a single-center experience. Int J Artif Organs. 2022;45(5):462–469. doi:10.1177/03913988221083993.
  • Hall SA, Uriel N, Carey SA, et al. Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. J Heart Lung Transplant. 2018;37(1):100–106. doi:10.1016/j.healun.2017.09.020.
  • Lima B, Kale P, Gonzalez-Stawinski GV, et al. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117(10):1622–1628. doi:10.1016/j.amjcard.2016.02.038.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.